Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,768.00
Bid: 2,700.00
Ask: 2,800.00
Change: 0.00 (0.00%)
Spread: 100.00 (3.704%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,768.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pricing of Issue of Notes

20 Feb 2024 16:01

RNS Number : 8158D
Coca-Cola HBC AG
20 February 2024

FOR IMMEDIATE RELEASE

Coca-Cola HBC Finance B.V.

(a private limited liability company incorporated in the Netherlands)

Guaranteed by:

Coca-Cola HBC AG

(a company incorporated with limited liability in Switzerland)

Pricing of Issue of Notes

Zug, Switzerland and Amsterdam, The Netherlands - 20 February 2024 - Further to the announcement earlier today, Coca-Cola HBC Finance B.V. (the "Issuer") and Coca-Cola HBC AG ("Coca-Cola HBC") announce the pricing of a ?600 million aggregate principal amount of 3.375% Notes due 2028, to be issued by the Issuer under its ?5,000,000,000 Euro Medium Term Note Programme.

The Notes will be guaranteed by Coca-Cola HBC.

This announcement must be read in conjunction with the Base Prospectus dated 19 December 2023, as supplemented on 15 February 2024 (the "Base Prospectus"), which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018, as amended.

Application will be made for the Notes to be admitted to the Official List of the Financial Conduct Authority and to trading on the Regulated Market of the London Stock Exchange plc. Settlement and the issue of the Notes are expected to occur on 27 February 2024.

Disclaimer

Neither this announcement nor the Base Prospectus constitute an offer of securities for sale in the United States. The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Notes will be offered only in offshore transactions to non-U.S. persons in reliance upon Regulation S under the Securities Act.

Please note that the information contained in this announcement and/or the Base Prospectus referred to above may be addressed to and/or targeted at persons who are residents of particular countries (specified in this announcement and/or the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in this announcement and/or the Base Prospectus is not addressed. Prior to relying on the information contained in this announcement and/or the Base Prospectus you must ascertain from this announcement and the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirements.

Enquiries

Coca?Cola HBC Group

Investors and Analysts:

John Dawson

Investor Relations Director (Interim)

Tel: +44 7552 619509

john.dawson@cchellenic.com

Jemima Benstead

Investor Relations Manager

Tel: +44 7740 535130

jemima.benstead@cchellenic.com

Virginia Phillips

Investor Relations Manager

Tel: +44 7864 686582

virginia.phillips@cchellenic.com

Media:

Sonia Bastian

Head of Communications

Tel: +41 7946 88054

sonia.bastian@cchellenic.com

Claire Evans

Group Senior Communications Manager

Tel: +44 7597 562 978

claire.evans@cchellenic.com

ABOUT COCA-COLA HBC

Coca-Cola HBC is a growth-focused consumer packaged goods business and strategic bottling partner of The Coca-Cola Company. We open up moments that refresh us all, by creating value for our stakeholders and supporting the socio-economic development of the communities in which we operate. With a vision to be the leading 24/7 beverage partner, we offer drinks for all occasions around the clock and work together with our customers to serve 740 million consumers across a broad geographic footprint of 29 countries. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, with consumer-leading beverage brands in the sparkling, adult sparkling, juice, water, sport, energy, ready-to-drink tea, coffee, and premium spirits categories. These include Coca-Cola, Coca-Cola Zero Sugar, Fanta, Sprite, Schweppes, Kinley, Costa Coffee, Caffè Vergnano, Valser, FuzeTea, Powerade, Cappy, Monster Energy, Finlandia Vodka, The Macallan, Jack Daniel's and Grey Goose. We foster an open and inclusive work environment amongst our 33,000 employees and believe that building a more positive environmental impact is integral to our future growth. We rank among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG, FTSE4Good and ISS ESG.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and is listed on the Athens Exchange (ATHEX: EEE). For more information, please visit https://www.coca-colahellenic.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IODURVVRSWUUUAR
Date   Source Headline
19th Sep 201810:26 amRNSDirector/PDMR Shareholding
3rd Sep 201812:26 pmRNSIssue of equity and total voting rights
20th Aug 201811:45 amRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSSTRONG VOLUME GROWTH DELIVERS GOOD RESULTS
1st Aug 20189:48 amRNSIssue of equity and total voting rights
26th Jul 20182:25 pmRNSDirector/PDMR Shareholding
18th Jul 201811:44 amRNSDirector/PDMR Shareholding
5th Jul 20183:46 pmRNSNotice of Results
2nd Jul 201810:13 amRNSIssue of equity and total voting rights
18th Jun 20181:42 pmRNSDirector/PDMR Shareholding
11th Jun 20183:20 pmRNSComposition of the Committees of the BoD of CCHBC
11th Jun 20182:35 pmRNSResult of AGM
1st Jun 201810:05 amRNSIssue of equity and total voting rights
18th May 20181:06 pmRNSDirector/PDMR Shareholding
15th May 20181:11 pmRNSDirector/PDMR Shareholding
15th May 20181:01 pmRNSDirector/PDMR Shareholding
15th May 201812:44 pmRNSDirector/PDMR Shareholding
10th May 20187:00 amRNSCONTINUING TO DELIVER BALANCED REVENUE GROWTH
8th May 201810:01 amRNSNotice of AGM
8th May 20189:20 amRNSChange to Board and dividend dates
4th May 20181:31 pmRNSAthens Exchange trading date of ordinary shares
1st May 20189:52 amRNSBlock listing Interim Review
1st May 20189:42 amRNSIssue of equity and total voting rights
18th Apr 20182:23 pmRNSDirector/PDMR Shareholding
13th Apr 20182:27 pmRNSNotice of Results
3rd Apr 201810:31 amRNSIssue of equity and total voting rights
19th Mar 20182:54 pmRNSDirector/PDMR Shareholding
16th Mar 20182:41 pmRNSDirector/PDMR Shareholding
16th Mar 20189:07 amRNSAnnual Financial Report
9th Mar 20184:03 pmRNSDirector/PDMR Shareholding
1st Mar 201812:32 pmRNSIssue of equity and total voting rights
27th Feb 20181:05 pmRNSDirector/PDMR Shareholding
26th Feb 20183:33 pmRNSDirector/PDMR Shareholding
23rd Feb 201810:53 amRNSDirector/PDMR Shareholding
22nd Feb 20184:28 pmRNSHolding(s) in Company
22nd Feb 20183:02 pmRNSDirector/PDMR Shareholding
21st Feb 201810:21 amRNSDirector/PDMR Shareholding
21st Feb 201810:13 amRNSDirector/PDMR Shareholding
20th Feb 20182:16 pmRNSDirector/PDMR Shareholding
20th Feb 20181:31 pmRNSDirector/PDMR Shareholding
20th Feb 20181:19 pmRNSDirector/PDMR Shareholding
20th Feb 20181:00 pmRNSDirector/PDMR Shareholding
16th Feb 201811:22 amRNSDirector/PDMR Shareholding
14th Feb 20187:00 amRNSEXCEPTIONAL SET OF RESULTS
1st Feb 201810:35 amRNSIssue of equity and total voting rights
19th Jan 20184:02 pmRNSDirector/PDMR Shareholding
17th Jan 201811:05 amRNSNotice of Results
5th Jan 20184:02 pmRNSAthens Exchange trading date of ordinary shares
2nd Jan 201810:04 amRNSIssue of equity and total voting rights
20th Dec 20172:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.